Swertiamarin ameliorates diet-induced obesity by promoting adipose tissue browning and oxidative metabolism in preexisting obese mice: Swertiamarin reverses obesity by enhancing energy expenditure

Obesity is a risk factor for many metabolic diseases. Efficient therapeutic strategies are urgently needed. Swertiamarin (STM) prevents obesity and the associated insulin resistance and inflammation. However, the therapeutic effects of STM on preexisting obesity remain unclear. Therefore, in this st...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Yuqin, Li, Haoran, Ma, Mengchen, Li, Dandan, Zhang, Ouyang, Cai, Suili, Wang, Yajiao, Chen, Dandan, Jin, Shengnan, Ding, Chunming, Xu, Liang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10157627/
https://www.ncbi.nlm.nih.gov/pubmed/36305727
http://dx.doi.org/10.3724/abbs.2022154

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10157627/
https://www.ncbi.nlm.nih.gov/pubmed/36305727
http://dx.doi.org/10.3724/abbs.2022154

Ejemplares similares